Compare · AUGX vs IPOF
AUGX vs IPOF
Side-by-side comparison of Augmedix Inc. (AUGX) and Social Capital Hedosophia Holdings Corp. VI (IPOF): market cap, price performance, sector, and recent activity on the wire.
Summary
- AUGX operates in Consumer Discretionary, while IPOF operates in Finance - the two are in different parts of the market.
- IPOF is the larger of the two at $1.41B, about 14.7x AUGX ($96.2M).
- AUGX has more recent analyst coverage (10 ratings vs 0 for IPOF).
- Company
- Augmedix Inc.
- Social Capital Hedosophia Holdings Corp. VI
- Price
- $2.35+0.21%
- $10.04+0.00%
- Market cap
- $96.2M
- $1.41B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 0
- 0
- Recent ratings
- 10
- 0
Augmedix Inc.
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. It offers software that is compatible with off-the-shelf, mobile client devices, which enables clinicians to communicate with remotely located documentation specialists (RDSs). The company's services include Augmedix Live, a real time service, in which RDSs provide medical documentation and live clinical support services; and Augmedix Notes, a non-real time product where RDSs offer medical documentation based upon recorded visits. Its clients include health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.
Social Capital Hedosophia Holdings Corp. VI
Social Capital Hedosophia Holdings Corp. VI intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the technology industries. The company was founded in 2020 and is based in Palo Alto, California.
Latest AUGX
- SEC Form 15-12G filed by Augmedix Inc.
- Director Redmile Group, Llc returned $75,402,504 worth of shares to the company (32,086,172 units at $2.35) (SEC Form 4)
- SEC Form 4 filed by Director Faulkner Robert C.
- Amendment: SEC Form SC 13D/A filed by Augmedix Inc.
- Director Febbo William J returned $382,070 worth of shares to the company (162,583 units at $2.35), closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by SVP, ENGINEERING Levy Tomer
- CHIEF TECHNOLOGY OFFICER Chatterjee Saurav returned $13,733 worth of shares to the company (5,844 units at $2.35), closing all direct ownership in the company (SEC Form 4)
- CHIEF OPERATING OFFICER Breber Sandra returned $47,693 worth of shares to the company (20,295 units at $2.35), closing all direct ownership in the company (SEC Form 4)
- Director O'Reilly Roderick H. returned $50,755 worth of shares to the company (21,598 units at $2.35), closing all direct ownership in the company (SEC Form 4)
- CHIEF FINANCIAL OFFICER Ginocchio Paul returned $319,118 worth of shares to the company (135,795 units at $2.35), closing all direct ownership in the company (SEC Form 4)
Latest IPOF
- SEC Form 15-12G filed by Social Capital Hedosophia Holdings Corp. VI
- SEC Form 25-NSE filed by Social Capital Hedosophia Holdings Corp. VI
- Billionaire VC Chamath Palihapitiya Sells Clover Health Shares: Is He No Longer Bullish?
- SEC Form SC 13G filed by Social Capital Hedosophia Holdings Corp. VI
- SEC Form 25-NSE filed by Social Capital Hedosophia Holdings Corp. VI
- Social Capital Hedosophia Holdings Corp. VI filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- Chamath Palihapitiya Liquidating 2 SPACs: Are Dreams Of Creating The Next Berkshire Hathaway Over?
- Chamath Palihapitiya Says 'Today, we started the process of winding down IPOD and IPOF.' And Says 'the funds raised by IPOD and IPOF will be returned to their respective shareholders'
- Social Capital Hedosophia Holdings Corp. VI filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Chamath Palihapitiya's SPAC Track Record Means Double-Digit Losses For You. Here Are The Details On All His Deals